References
- Jones HR. Childhood Guillain Barre syndrome: clinical presentation, diagnosis, and therapy. J Child Neurol 1996;11:4–12.
- Sabogal CE. Index of suspicion: Guillain-Barre syndrome. Pediatr Rev. 1997;18 (10):357–359.
- Norman M, Elinder G, Finkel Y Vincristine neuropathy and a Guillain—Barre syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol. 1987;39:75–76.
- Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy: a clinical study of fifty leukemic patients. Neurology. 1969;19:367–374.
- McLeod JG, Penny R. Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychiatry. 1969;32:297–304.
- Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man. J Neurol Sci. 1970;10:107–131.
- van der Meche FGA, Visser LH, Jacobs BC, Endtz HPh, Meulstee J, van Doom PA. Guillain—Barré syndrome: multifactorial mechanisms versus defined subgroups. J Infect Dis. 1997;176(Suppl 2):S99—S102.
- Rosenthal S, Kaufman S. Vincristine neurotoxicity. Ann Intern Med. 1974;80:733–737.
- Hughes RA, Hadden RD, Gregson NA, Smith lg. Pathogenesis of Guillain—Barré syndrome. J Neu-roimmunol 1999;100(1-2):74–97.
- Abd-Allah SA, Jansen PW, Ashwal S, Perkin RM. Intravenous immunoglobulin as therapy for pediatric Guillain—Barré syndrome. J Child NeuroL 1997;12:376–380.